Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.89 USD | -0.41% | +3.82% | +1.54% |
08/05 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
07/05 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.54% | 1.85B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.23% | 12.42B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- BTIG Initiates Apollo Medical at Buy Rating With $45 Price Target